至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Enhancement of antifungal activity of Burkholderia pyrrocinia JK‐SH007 genetically modified with Bacillus subtilis Chi113 gene

Forest Pathology. 2016-01; 
L.‐M. He J.‐R. Ye J.‐H. Ren L. Huang X.‐Q. Wu
Products/Services Used Details Operation
Custom DNA/RNA Oligos … Primers, Oligomeric sequences (5'–3')a a All the oligonucleotides were designed by Primer Premier Version 5.0 and synthesized by GenScript Corp. (Nanjing, China) a All the oligonucleotides were designed by Primer Premier Version 5.0 and synthesized by GenScript Get A Quote

摘要

Previous studies showed that Burkholderia pyrrocinia JK‐SH007 is a potential biocontrol agent of poplar canker disease. In this report, B. pyrrocinia JK‐SH007 was genetically modified by introducing the Bacillus subtilis Chi113 gene to enhance its antifungal activity. The green fluorescence of B. pyrrocinia JK‐SH007E1 can be detected because of its transformation with plasmid pHKT2‐Chi113 containing a gfp reporter gene. Real‐time quantitative PCR (qPCR) showed that the B. subtilis Chi113 gene was highly expressed in B. pyrrocinia JK‐SH007E1 at mRNA level. The chitinase activity and the antifungal activity of B. pyrrocinia JK‐SH007E1 were significantly increased, and the clear halo was visible on t... More

关键词